SCHEMBL5281855

SCHEMBL5281855

COC(=O)c1ccc(NS(=O)(=O)c2ccc(Cl)c3onnc23)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
IKBKB O14920 2/20 0.46
HPGD P15428 3/20 0.46
LMNA P02545 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.43
MAPT P10636 2/20 0.43
GAA P10253 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
POLB P06746 2/20 0.42
HSD17B10 Q99714 1/20 0.42
MAPK1 P28482 1/20 0.41
CMA1 P23946 1/20 0.41
ALPL P05186 1/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5284618 0.81 RORA (0.60) ALDH1A1IKBKBHPGDLMNAMEN1
SCHEMBL3268660 0.73 ITGA1 (0.68) ALDH1A1HPGDLMNAMEN1KMT2A
SCHEMBL6397094 0.71 ALDH1A1 (0.54) ALDH1A1HPGDLMNAMEN1KMT2A
SCHEMBL6392109 0.70 ALDH1A1 (0.53) ALDH1A1HPGDLMNAMEN1KMT2A
SCHEMBL5291761 0.70 KMT2A (0.49) ALDH1A1IKBKBHPGDLMNAMEN1
SCHEMBL8160125 0.69 ALDH1A1 (0.69) ALDH1A1LMNAMEN1KMT2ASMN1; SMN2
SCHEMBL25072430 0.68 HPGD (0.50) ALDH1A1HPGDLMNAMEN1KMT2A
SCHEMBL25315174 0.68 MAPT (0.80) ALDH1A1HPGDLMNAMEN1KMT2A
SCHEMBL17210223 0.68 ALDH1A1 (1.00) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL5244028 0.67 MYC (0.51) ALDH1A1IKBKBHPGDLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758873-A1 UBIQUITIN LIGASE INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2007-03-07 EP disclosed
WO-2006002284-A1 UBIQUITIN LIGASE INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2006-01-05 WO disclosed